{
  "id": "52c2b60737398e33",
  "title": "Genmab A / S : Genmab Presents Pivotal Phase 3 Data from EPCORE FL - 1 Trial Demonstrating Clinical Benefit of EPKINLY ( epcoritamab - bysp ) in Combination with Rituximab and Lenalidomide ( R2 ) in Patients with Relapsed or Refractory Follicular Lym...",
  "description": "20251207T133000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2025-12/67166156-genmab-a-s-genmab-presents-pivotal-phase-3-data-from-epcore-fl-1-trial-demonstrating-clinical-benefit-of-epkinly-epcoritamab-bysp-in-combination-wi-004.htm",
  "published_at": "20251207T133000Z",
  "fetched_at": "2025-12-08T00:22:54.837391+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2025-12/67166156-genmab-a-s-genmab-presents-pivotal-phase-3-data-from-epcore-fl-1-trial-demonstrating-clinical-benefit-of-epkinly-epcoritamab-bysp-in-combination-wi-004.htm",
    "url_mobile": "",
    "title": "Genmab A / S : Genmab Presents Pivotal Phase 3 Data from EPCORE FL - 1 Trial Demonstrating Clinical Benefit of EPKINLY ( epcoritamab - bysp ) in Combination with Rituximab and Lenalidomide ( R2 ) in Patients with Relapsed or Refractory Follicular Lym...",
    "seendate": "20251207T133000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-genmab-a-s-aktie-intraklein-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}